Webcast CME

Series Activities

Series Menu

Pathology & Laboratory Medicine Grand Rounds 2020
Webcasts

Clinical Implications of Advanced Molecular Subtyping of Diffuse Large B-Cell Lymphoma: The Dawn of a New Era

Print this Content

Release date: March 20, 2020
Expiration date: March 20, 2022

Estimated Time of Completion: 45 minutes

Description

Pathology & Laboratory Medicine Grand Rounds 2020 CME-certified webcast series features presentations from the Pathology & Laboratory Medicine Institute Grand Rounds. Faculty provide evidence-based guidance on the diagnosis and management of challenging cases in prostate disease, renal neoplasms, GI, hepatobiliary/ pancreatic, endometrial and uterine masses, pancreatic and lung cytology, bone and soft tissue lesions and pulmonary pathology. 

Learning Objectives

  1. Identify the new subtypes of diffuse large B-cell lymphoma as defined by molecular techniques
  2. Recognize current treatment approaches for diffuse large B-cell lymphoma
  3. Identify the potential to use molecular subtyping to improve treatment outcomes for patients with diffuse large B-cell lymphoma

Target Audience

The online series is designed for pathologists and allied health practitioners and students interested in pathology and laboratory medicine.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Continuing Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Lifelong Learning (Part II) / Self-Assessment Module (SAM) credits in the American Board of Pathology’s Continuing Certification (CC) program (formerly known as MOC). Participants will earn CC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABPath CC credit.

Activity Directors, Planning Committee and Faculty

Activity Directors

Steven Billings, MD
Co-section Head, Dermatopathology Section
Department of Anatomic Pathology
Pathology & Laboratory Medicine Institute
Cleveland Clinic
Cleveland, OH

Deborah Chute, MD
Pathology & Laboratory Medicine Institute
Cleveland Clinic
Cleveland, OH

Gary W. Procop, MD, MS
Medical Director and Co-Chair
Enterprise Laboratory Stewardship Committee
Director of Molecular Microbiology, Virology, Mycology and Parasitology
Pathology & Laboratory Medicine Institute
Cleveland Clinic
Cleveland, OH

Pathology & Laboratory Medicine Institute Planning Committee

Josephine Dermawan, PhD
Erinn Downs-Kelly, DO
Jennifer Jeung, MD
James Lapinski, MD
Olaronke Oshilaja, MD
Richard Prayson, MD
Christopher Przybycin, MD
Tricia Pua, MD
J. Jordi Rowe, MD

Faculty

Brian Hill, MD
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:

Brian Hill, MD Abbvie Pharmaceuticals
Consulting; Membership on advisory committee or review panels
Astra Zeneca; Bayer; Celgene Corporation; Genenetch; Novartis Oncology; Pharmacyclics Consulting
Kite Pharma Inc. Consulting; Research / Independent Contractor
Seattle Genetics Membership on advisory committee or review panels

The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Steven Billings, MD, Deborah Chute, MD, Josephine Dermawan, PhD, Erinn Downs-Kelly, DO, Jennifer Jeung, MD, James Lapinski, MD, Olaronke Oshilaja, MD, Richard Prayson, MD, Gary Procop, MD, Christopher Przybycin, MD, Tricia Pua, MD, J. Jordi Rowe, MD


This CME activity was produced by the Cleveland Clinic Center for Continuing Education and
Cleveland Clinic's Pathology & Laboratory Medicine Institute.